Bone Marrow Aspiration Pain Study
Biochemical and Genetic Mechanisms of Acute Clinical Pain During Bone Marrow Aspiration
Background:
- Many people feel pain during and after bone marrow aspiration (collection). Studies suggest that pain may be related to different kinds of inflammation, or the presence of nitric oxide (a normally occurring gas) in the body. Researchers want to study nitric oxide levels in the blood and breath before and after bone marrow collection. They will look at how these levels relate to feelings of pain.
Objectives:
- To better understand pain related to having a bone marrow collection.
Eligibility:
- Individuals at least 18 years of age who are enrolled in a study that requires bone marrow collection.
Design:
- Participants will be screened with a physical exam, medical history, and blood sample.
- Participants will provide study blood and breath samples to check nitric oxide levels. Participants will also have a test to measure skin sensitivity to heat and touch.
- During the collection, participants will keep track of their pain levels.
- After the collection, participants will keep track of any pain medications they take. They will also record if and when they eat any foods that contain nitrates for about 24 hours.
調査の概要
詳細な説明
Abstract:
This project will explore the biochemical mechanisms associated with acute pain produced by bone marrow aspiration in 36 healthy subjects by : 1) Evaluation of any strong relationships of NO metabolism (as measured by plasma nitrite, nitrosated proteins, cyclic GMP, plasma hemoglobin, reticulocytes, as well as markers of inflammation) with the levels of acute pain in healthy subjects and; 2) Identification of differentially expressed genes and proteins as markers for the nature and severity of pain from bone marrow aspiration. Elucidation of these relationships may identify novel targets for intervention leading to attenuation of pain, improved treatment and less impact on quality of life (QOL) and may identify potential mechanisms for the role of NO in other inflammatory or pain syndromes.
Objectives:
The first objective of the study is to characterize genetic expression during acute pain and pain free phases pre and post bone marrow aspiration (BMA). The second objective is to measure at multiple time points levels of exhaled Nitric Oxide (eNO) and other biomarkers in subjects during pre- and post BMA. The third objective is to evaluate acute and experimental pain perception in these subjects.
Population:
This study will recruit healthy subjects (N=36) who have agreed to donate bone marrow.
Design:
This is a prospective, exploratory study of sensory and affective pain in healthy volunteers. Participants will undergo evaluations (eNO, blood collection, and quantitative sensory testing) during a clinic visit to undergo bone marrow aspiration.
Importance:
The purpose of this study is to improve the understanding of the biochemical and molecular genetic mechanisms associated with acute pain in a healthy population by characterizing the leukocyte transcriptome of pain pre- and post BMA. It is hypothesized that analysis of the transcriptome will result in a panel of biomarkers that correlate with acute pain in a healthy population. The successful elucidation of these relationships may identify novel targets for intervention leading to attenuation of pain, improved treatment and less impact on quality of life and functional status.
研究の種類
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
- INCLUSION CRITERIA FOR SUBJECTS:
All subjects enrolled in the parent protocol are eligible for enrollment in this study provided they have met all the inclusion criteria in the parent protocol and if they meet all of the following criteria:
- Age greater than or equal to 18 years old.
- No chronic medication use that in the judgment of the investigators could confound the study or biomarker measurements.
- Can speak and understand English to complete assessments and scales
EXCLUSION CRITERIA FOR ALL STUDY PARTICIPANTS:
Study participants will be excluded from the study if he/she has one or more of the following:
- Inability to provide informed consent.
- Drug or alcohol dependence/abuse within the past 5 years
- Cigarette smoking or the use of any tobacco products within two years
- Use of tranquilizers, steroids, and non-steroidal anti-inflammatory agents three or more times per week.
Clinically significant medical condition that will confound the analysis of factors associated with pain, such as:
- Chronic inflammatory disease (i.e. rheumatoid arthritis, systemic lupus erythematosus, cirrhosis)
- Chronic pain condition
- Diabetes mellitus
- Known malignancies
研究計画
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
|---|
|
Differences over time between whole blood gene expression in the peripheral blood of healthy subjects undergoing an acute pain stimulus.
|
二次結果の測定
結果測定 |
|---|
|
Quantification and differences in laboratory correlates (particularly plasma nitrite, nitrosated proteins, and cyclic GMP) in health subjects pre- and post-BMA.
|
|
Quantification of pain sensory perception in healthy subjects
|
協力者と研究者
捜査官
- 主任研究者：Wendy B Smith, Ph.D.、National Institutes of Health Clinical Center (CC)
出版物と役立つリンク
一般刊行物
- McKerrell TD, Cohen HW, Billett HH. The older sickle cell patient. Am J Hematol. 2004 Jun;76(2):101-6. doi: 10.1002/ajh.20075.
- Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997 Mar 1;89(5):1787-92.
- The labrets of the northern "Esquimaux" (1826). Alaska Med. 1991 Apr-Jun;33(2):93. No abstract available.
研究記録日
主要日程の研究
研究開始
研究の完了
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
急性痛の臨床試験
-
Dexa Medica Group完了